statistiche ricercatore

RIVA, CRISTINA

Distribuzione geografica

Continente	#
NA - Nord America	5.057
EU - Europa	4.274
AS - Asia	891
Continente sconosciuto - Info sul continente non disponibili	13
SA - Sud America	10
OC - Oceania	4
AF - Africa	2
Totale	10.251

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	5.047
IT - Italia	2.190
UA - Ucraina	794
TR - Turchia	372
SE - Svezia	340
CN - Cina	266
DE - Germania	236
VN - Vietnam	225
IE - Irlanda	203
FI - Finlandia	195
FR - Francia	139
GB - Regno Unito	97
RU - Federazione Russa	19
BE - Belgio	17
NL - Olanda	15
EU - Europa	13
IN - India	11
CA - Canada	9
JP - Giappone	9
BR - Brasile	6
PL - Polonia	5
AT - Austria	3
AU - Australia	3
CH - Svizzera	3
CO - Colombia	3
DK - Danimarca	3
HR - Croazia	3
AE - Emirati Arabi Uniti	2
EG - Egitto	2
LU - Lussemburgo	2
AL - Albania	1
BO - Bolivia	1
ES - Italia	1
GR - Grecia	1
HU - Ungheria	1
ID - Indonesia	1
IS - Islanda	1
LB - Libano	1
LV - Lettonia	1
MD - Moldavia	1
MO - Macao, regione amministrativa speciale della Cina	1
MY - Malesia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PA - Panama	1
RO - Romania	1
SG - Singapore	1
SK - Slovacchia (Repubblica Slovacca)	1
TW - Taiwan	1
Totale	10.251

Salva come PNG Salva come JPEG

Città	#
Milan	1.560
Jacksonville	607
Chandler	586
Fairfield	578
Woodbridge	388
Dearborn	317
Ann Arbor	280
Ashburn	276
Wilmington	250
Houston	248
Princeton	214
Dublin	201
Seattle	201
Izmir	189
Nyköping	183
Cambridge	171
Rome	111
Dong Ket	110
San Mateo	88
Beijing	72
Como	71
New York	54
San Diego	50
Ogden	41
Hefei	26
Kunming	19
Boardman	18
Nanjing	17
Guangzhou	15
Verona	15
Brussels	14
Jinan	14
London	13
Los Angeles	13
Norwalk	13
Düsseldorf	12
Nanchang	12
Washington	10
Tokyo	8
Casorezzo	7
Catania	7
Fuzhou	7
Pune	7
Shenyang	7
Auburn Hills	6
Redwood City	6
Chicago	5
Kocaeli	5
Changsha	4
Chengdu	4
Edinburgh	4
Florence	4
Frankfurt am Main	4
Helsinki	4
Indiana	4
Mountain View	4
Rozzano	4
Warsaw	4
Amsterdam	3
Atlanta	3
Chiswick	3
Dallas	3
Hebei	3
Jinhua	3
Kilburn	3
Parma	3
Ponte Lambro	3
Prescot	3
Shaoxing	3
Toronto	3
Tunja	3
Vienna	3
Wuhan	3
Aversa	2
Avezzano	2
Baotou	2
Berlin	2
Castellammare di Stabia	2
Charlotte	2
Collecchio	2
Dubai	2
Fagnano Olona	2
Fiorenzuola D'arda	2
Gravina di Catania	2
Hangzhou	2
Lissone	2
Locate Di Triulzi	2
Manchester	2
Maryville	2
Montecchio Maggiore	2
Montreal	2
Québec	2
Redmond	2
Sioux Falls	2
Stezzano	2
Stockholm	2
Strasbourg	2
Taizhou	2
Tianjin	2
Vancouver	2
Totale	7.261

Salva come PNG Salva come JPEG

Nome	#
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO	230
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis	226
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics	200
Inherited cancer syndromes in 220 Italian ovarian cancer patients	185
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses	182
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes	180
Natural history of cervical intraepithelial neoplasia during pregnancy.	169
Carcinosarcoma of the uterine cervix: Case report and discussion.	167
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis	167
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	164
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome	162
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis	157
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case	153
Biochemical and immunohistochemical characterization of human RNASET2 expression	147
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature	145
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling	145
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.	144
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences	139
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis	138
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers	135
Identifying factors contributing to reduced breast tumor size: A longitudinal study	132
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene	129
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas	123
Disorders of the Endocrine System	122
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study	119
Early Involvement of 6q in Surface Epithelial Ovarian Tumors	114
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001	113
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.	113
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors	107
Diabetic fibrous mastopathy: sonographic-pathologic correlation	107
Microsatellite instability in endometrial cancer. Relation to histological subtypes	104
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer.	103
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours	101
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations.	100
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts	99
Fetoplacental cytomegalovirus infection. A case report	98
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas	98
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.	98
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro	97
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells	96
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	95
CD44 expression in ER and PR negative ductal breast carcinomas	95
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms.	94
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene.	94
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I	94
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS	91
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	87
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA	87
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids	86
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms	85
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999	85
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE	85
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI	85
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas”	84
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas	84
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy	84
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression	83
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	83
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas	83
RNASET2 is a non-cell autonomous human tumor suppressor	82
Androgen receptors in breast	82
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia	81
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment	80
Prognostic significance of karyotype analysis in ovarian carcinomas	80
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas	80
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas	79
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology	79
Pituitary adenomas, a thirty-four-years experience in a –single institution.	79
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression	78
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study	78
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis	77
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas.	77
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	77
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms	76
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas.	76
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers	75
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas	75
Clinicopathological features of oral carcinoma: analysis of 240 cases	74
IL CARCINOMA MICROINVASIVO DELLA CERVICE	73
The applications of FISH in tumor pathology	72
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis	71
p53 positive, breast cancers frequently express basal and myoepithelial cell markers	71
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT	68
Expression of gastrointestinal markers in pancreatic carcinomas	68
Prognostic significance of karyotype analysis in ovarian carcinomas	66
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas.	66
Molecular genetics of syncronous endometrial and ovarian carcinomas	65
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento	65
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases.	64
Espressione del recettore degli androgeni nel carcinoma mammario	63
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION	63
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST	62
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale.	61
Classification and histogenesis of gastroenteropancreatic endocrine tumors.	59
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS	56
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis	54
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression.	52
Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.Virchows Archiv	51
Capitolo 9.7: Intestino tenue	45
Ano	44
Totale	10.016

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	32.618
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	32.618

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	1.785	71	65	64	275	77	277	338	226	100	142	25	125
2020/2021	1.569	19	244	98	165	48	162	50	130	228	65	145	215
2021/2022	1.054	106	126	96	76	46	37	37	69	53	161	83	164
2022/2023	1.460	127	99	105	195	91	299	3	201	219	35	59	27
2023/2024	2.348	394	388	400	413	470	149	9	17	57	16	17	18
2024/2025	5	5	0	0	0	0	0	0	0	0	0	0	0
Totale													10.317